Xacduro

LaJolla Pharmaceutical Company🇺🇸 United States

FDA Page

Effective Date: Nov 26, 2025
Approval ID: c0167aec-a89d-4e96-afe5-2ccf3e89fe72
Products: 1 registered
Version: 6

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XACDURO safely and effectively. See full prescribing information for XACDURO. XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use Initial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.